Patients lack timely diagnosis and access to effective antibiotics
#00368
Many patients, especially in resource-limited settings, cannot obtain timely microbiology, susceptibility testing, or the effective antibiotics needed to treat resistant infections.
Parent issue
#00365 Antibiotic-resistant bacterial infections make common treatment increasingly unreliable
Sustainable Development Goals
Location
Description
Patients with serious bacterial infections may receive ineffective treatment because laboratories cannot identify the pathogen or its resistance profile quickly enough, local resistance data are unavailable, or effective antibiotics are not registered, affordable, stocked, or formulated for the patient group.
The GBD 2021 antimicrobial resistance analysis estimated that improved care for severe infections and better antibiotic access could avert 92 million deaths from bacterial infections between 2025 and 2050. WHO also reports that some countries record no consumption of Reserve antibiotics despite need for them in selected multidrug-resistant infections. (WHO antibiotic consumption report)
This issue covers diagnostic and treatment access. It does not justify uncontrolled antibiotic distribution, which can worsen resistance and patient safety.
Sub-issues
0Top solutions
2